Athira CEO placed on temporary leave pending review of WSU research

Bothell, Washingto-based Athira Pharma has placed CEO Leen Kawas on temporary leave as the company reviews actions stemming from her doctoral research at Washington State University. The company didn't specify what about Kawas' research it was investigating in its release, but it said an independent special committee formed by the board will lead the review. Athira added that it won't comment further on the matter until after the review, and Kawas will remain on the board. "A thira is committed…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news